Skip Navigation

Biodefense and Emerging Infectious Diseases

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +


Click to expand or collapse content.

Category A Pathogens

Open All

Bacillus anthracis (Anthrax)


Clostridium botulinum (Botulism)
Botulinum toxin serotypes A, B and E


Dengue virus


Ebola and Marburg viruses


Marburg virus




Yersinia pestis (Plague)


Variola major (Smallpox)


Category B Pathogens

Open All

West Nile virus


Category C Pathogens

Open All

Chikungunya virus


Influenza virus




Severe Acute Respiratory Syndrome-associated Coronavirus (SARS)




Broad-Spectrum Therapies (Various Categories)

Open All

Broad-Spectrum Antimicrobial Therapies


Broad-Spectrum Antivirals (implications for pox viruses, cytomegalovirus, herpes simplex viruses, Epstein Barr Virus, adenovirus, BK virus, JC virus, papilloma virus)


Broad-Spectrum Antivirals Against All Enveloped Viruses (implications for HIV-1, Influenza, Ebola, Rift Valley Fever, and Nipah virus)



Open All

Diagnostic for Respiratory Pathogens (Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza B, Respiratory Syncytial Virus, human Metapneumovirus, Coronavirus NL63, Coronavirus OC43, Coronavirus 229E, Coronavirus HKU1, Adenovirus, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4, Bocavirus, Rhinovirus, Bordatella pertussis, Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Streptococcus pneumonia)

back to top

Last Updated March 17, 2014

Last Reviewed September 19, 2011